BV
Bavarian Nordic A/S
BVNRY · OTC
$10.50 +0.12% (+$0.01)
1M +13.36%
Market Cap 15.6B kr
P/E Ratio 10.04x
Div. Yield -
ROE 12.00%
Bulios Fair Price
$11.83
12.7% upside
Current Price
$10.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BVNRY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
96 /100
Cheap PEG 0.35x
P/E 10.04x
P/B 1.18x
Growth
100 /100
Growing Book val. growth 21.64%
Rev. growth 23.49%
FCF growth N/A
Profitability
91 /100
Strong Op. margin 16.57%
Gross margin 51.72%
FCF margin 20.21%
Quality
47 /100
Average ROA 10.58%
ROIC 5.67%
Asset turnover 0.41x
Debt
100 /100
Low Int. coverage 137.78x
Debt/Equity 0.01x
Net debt/EBITDA -0.24x
Stability
32 /100
Unstable EPS volatility 285.42%
Beta 0.94x
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BVNRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul John Chaplin
Employees
1,795
Headquarters
Hellerup